J D Hipp1, J A Hipp, B W Lyday
1Cancer Center, University of California-San Diego, La Jolla, CA 92093-0060, USA.
This review explores cutting-edge cancer vaccine designs, including peptide, viral, and DNA vaccines, alongside dendritic cell immunotherapy. It highlights promising tumor antigens and future directions for effective cancer immunotherapy.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: